Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Sosei Group ( (JP:4565) ) just unveiled an announcement.
Nxera Pharma Co., Ltd. has announced a buyback and consent solicitation for its existing convertible bonds due in 2028. The company aims to amend the terms of these bonds to reduce near-term redemption risk and secure liquidity for strategic growth investments. By removing bondholders’ early redemption options and conducting a tender offer up to ¥5 billion, Nxera seeks to maintain lower funding costs and avoid dilutive effects on shareholders.
The most recent analyst rating on (JP:4565) stock is a Hold with a Yen767.00 price target. To see the full list of analyst forecasts on Sosei Group stock, see the JP:4565 Stock Forecast page.
More about Sosei Group
Average Trading Volume: 722,385
Technical Sentiment Signal: Strong Sell
Current Market Cap: Yen78.01B
See more data about 4565 stock on TipRanks’ Stock Analysis page.